TPST
Tempest Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
−3.86%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
3713.0%
Return on equity
-420.1%
Return on assets
-628.2%
Return on invested capital
0.00x
Asset turnover
-$20.7M
Cash from operations
$0.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026